Free Trial
ASX:AEF

Australian Ethical Investment (AEF) Stock Price, News & Analysis

Australian Ethical Investment logo

About Australian Ethical Investment Stock (ASX:AEF)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
228,104 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
2.17%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Australian Ethical Investment Ltd is a publicly owned investment manager. The firm launches and manages equity, fixed income, and balanced mutual funds for its clients. It invests in the public equity and fixed income markets across the globe. The firm invests in education, energy, electricity transmission & distribution, government, health & wellbeing, food production, telecommunications, transport, recycling and waste management, sustainable products & materials, Information technology, software and professional services, media, property, recreation financial services. The firm employs fundamental analysis to create its portfolios. Australian Ethical Investment Ltd was founded in 1986 and is based in Sydney, Australia.

Receive AEF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Australian Ethical Investment and its competitors with MarketBeat's FREE daily newsletter.

AEF Stock News Headlines

3 ASX Growth Stocks With Insider Ownership Up To 38%
This Crypto Is Set to Explode in January
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…
Australian Ethical Investment Limited
Australian Ethical Boosts Stake in Janison Education Group
See More Headlines

AEF Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Australian Ethical Investment investors own include Adobe (ADBE), Ashford Hospitality Trust (AHT), Allakos (ALLK), Advanced Micro Devices (AMD), Amedisys (AMED), Alibaba Group (BABA) and BioXcel Therapeutics (BTAI).

Industry, Sector and Symbol

Industry
Asset Management
Sub-Industry
Financial Services
CIK
N/A
Fax
N/A
Employees
126
Year Founded
N/A

Profitability

Net Income
$11.53 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$100.49 million
Book Value
A$0.27 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
1.66
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

This page (ASX:AEF) was last updated on 1/15/2025 by MarketBeat.com Staff
From Our Partners